HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial

by Cassidy W. Claassen MD, MPH, David Keckich MD, Chidi Nwizu MBBS, Alash’le Abimiku PhD, Donald Salami MPH, Michael Obiefune MBBS, Bruce L. Gilliam MD, Anthony Amoroso MD
Published 2019-01-01

Long-Term Outcome of Second-Line Antiretroviral Therapy in Resource-Limited Settings

by Olukemi Osinusi-Adekanmbi MD, MPH, Kristen Stafford MPH, Adiba Ukpaka MBBS, Donald Salami MSc, Samuel Ajayi MBBS, Nicaise Ndembi PhD, Alash’le Abimiku PhD, Chidi Nwizu MD, Bruce Gilliam MD, Robert Redfield MD, Anthony Amoroso MD
Published 2014-07-01

Operation Save the World from Adverse Drug Reactions: findings from a drug safety surveillance programme in Nigeria

by Yohanna Kambai Avong, MPH, Bolajoko Jatau, MPH, Gbenga Ayodele Kayode, PhD, Blessing Ukpabi, MSc, Eunice Bosede Avong, MPH, James Okuma, MS, Dennis Mordi, MSc, Alash'le Abimiku, PhD, Obinna Ogbanufe, MPH, Charles Olalekan Mensah, MBA, Patrick Dakum, MPH
Published 2019-03-01